Compare Nu Holdings Ltd (NU) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nu Holdings Ltd vs TG Therapeutics Inc — how do they compare? Nu Holdings Ltd trades at $14.36 (market cap $67.58B), while TG Therapeutics Inc trades at $54.06 (market cap $8.26B). The key difference: Nu Holdings Ltd is far larger — about 8.2× TG Therapeutics Inc's market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Nu Holdings Ltd nearer its low. Which is the better fit depends on your goals.
| NU | TGTX | |
|---|---|---|
Market Cap | $67.58B | $8.26B |
Sector | Financials | Health |
52-Week High | $18.76 | $59.06 |
52-Week Low | $11.60 | $26.39 |
Enterprise Value | — | $8.50B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nu Holdings Ltd
Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Account, and Rewards.
Read more on NU →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
